BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19330493)

  • 1. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.
    Kohlmann O; Roca-Cusachs A; Laurent S; Schmieder RE; Wenzel RR; Fogari R
    Adv Ther; 2009 Mar; 26(3):313-24. PubMed ID: 19330493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
    Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
    Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
    Coca A
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):147-59. PubMed ID: 17338661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of efficacy and tolerability of Losartan and Ramipril combination in the management of hypertensive patients with associated diabetes mellitus in India (LORD Trial).
    Joshi SR; Yeolekar ME; Tripathi KK; Giri J; Maity AK; Chopda M; Gujarathi S; Maroli S; Maity A;
    J Assoc Physicians India; 2004 Mar; 52():189-95. PubMed ID: 15636307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
    Mugellini A; Preti P; Zoppi A; Corradi L; Fogari E; Derosa G; Fogari R
    J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
    Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
    Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
    Fogari R; Mugellini A; Circelli M; Cremonesi G
    Clin Drug Investig; 2011; 31(7):439-53. PubMed ID: 21627336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria.
    Fogari R; Corradi L; Zoppi A; Lazzari P; Mugellini A; Preti P; Rinaldi A
    Am J Hypertens; 2007 Oct; 20(10):1092-6. PubMed ID: 17903693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA;
    J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.